TargetMol

PMPMEase-IN L-28

Product Code:
 
TAR-T24651
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T24651-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T24651-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T24651-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
PMPMEase-IN L-28 is a novel inhibitor of prenylated methylated protein methylesterase.
CAS:
1190196-77-0
Formula:
C17H29FO2S2
Molecular Weight:
348.54
Purity:
0.98
SMILES:
CC(C)=CCCC(C)=CCCC(C)=CCSCCS(F)(=O)=O

References

1. Leisser A, Nejabat M, Hartenbach M, Agha Mohammadi Sareshgi R, Shariat S, Kramer G, Krainer M, Hacker M, Haug AR. Analysis of hematological parameters as prognostic markers for toxicity and survival of (223)Radium treatment. Oncotarget. 2018 Mar 5;9(22):16197-16204. doi: 10.18632/oncotarget.24610. eCollection 2018 Mar 23. PubMed PMID: 29662636; PubMed Central PMCID: PMC5882327. 2. Philippe C, Gr?goir AF, Thor? ESJ, Brendonck L, De Boeck G, Pinceel T. Acute sensitivity of the killifish Nothobranchius furzeri to a combination of temperature and reference toxicants (cadmium, chlorpyrifos and 3,4-dichloroaniline). Environ Sci Pollut Res Int. 2018 Apr;25(10):10029-10038. doi: 10.1007/s11356-018-1278-x. Epub 2018 Jan 29. PubMed PMID: 29380199. 3. DasGupta RK, Levine L, Wiczer T, Cataland S. Initial romiplostim dosing and time to platelet response in patients with treatment refractory immune thrombocytopenia. J Oncol Pharm Pract. 2018 Jan 1:1078155217748470. doi: 10.1177/1078155217748470. [Epub ahead of print] PubMed PMID: 29298625. 4. Kali?czuk ?, Zieli?ski K, Pr?gowski J, Przy?uski J, Karcz M, Bekta P, Ciszewski M, Dzieli?ska Z, Witkowski A, Demkow M. Higher admission glycaemia independently of diagnosed or unrecognised diabetes mellitus is a risk factor for failed myocardial tissue reperfusion and higher mortality after primary angioplasty. Kardiol Pol. 2018;76(3):594-601. doi: 10.5603/KP.a2017.0258. Epub 2018 Jan 3. PubMed PMID: 29297192.